We found that by all examined criteria, including cellular metabolic activity (Alamar Blue assay), observed percentage of dead cells (Trypan Blue Staining) and assessment of cellular apoptosis (Annexin V/PI staining), the combination of Th1 cytokines and lapatinib acted in concert to maximize the negative impact on the tumor cells. This evidence concerns the gene ANXA5 and neoplasm.